DYSTROGEN THERAPEUTICS

dystrogen-therapeutics-logo

Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases. The company was founded based on the pioneering work of Prof. Maria Siemionow, a world-renowned scientist and surgeon who led the team that performed the first near-total face transplantation in the United States. Professor Siemionowโ€™s research focused on the creation of chimeric cells. This led to the development of Dystrophin Expressing Chimeric (DEC) cell therapy. DECs work by combining a ma... lfunctioning cell of the Duchenne patient with a normal, working cell from a healthy donor. This novel chimeric cell is composed of both the donor and the recipient structures and interacts with the surroundings like a normal cell. This offers a unique advantage and allows the patient's body and immune system to accept the chimeric cell without rejection. In such a way, we have created dystrophin producing cells that can engraft the patient's muscles (such as heart, diaphragm, skeletal muscles) and increase their dystrophin levels. Increased dystrophin levels have been shown to correlate with improved functional outcomes. This technology was developed at the University of Illinois in Chicago. Dystrogen Therapeutics is currently focused on the development of a cell-based therapy platform. The company is testing dystrophin expressing chimeric (DEC) cells, cell-based therapy for the treatment of Duchenne muscular dystrophy.

#SimilarOrganizations #People #Website #More

DYSTROGEN THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics Wellness

Founded:
2017-01-01

Address:
Chicago, Illinois, United States

Country:
United States

Website Url:
http://www.dystrogen.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
1.09 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box


Similar Organizations

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

pandion-therapeutics-logo

Pandion Therapeutics

Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.


Current Advisors List

paul-lewicki_image

Paul Lewicki Co-Founder and Board Member @ Dystrogen Therapeutics
Board_member

Current Employees Featured

kris-siemionow_image

Kris Siemionow
Kris Siemionow Co-Founder and CEO @ Dystrogen Therapeutics
Co-Founder and CEO

maria-siemionow_image

Maria Siemionow
Maria Siemionow Founder and Chief Scienti๏ฌc O๏ฌƒcer @ Dystrogen Therapeutics
Founder and Chief Scienti๏ฌc O๏ฌƒcer

Founder


kris-siemionow_image

Kris Siemionow

maria-siemionow_image

Maria Siemionow

paul-lewicki_image

Paul Lewicki

Official Site Inspections

http://www.dystrogen.com

  • Host name: 169.41.180.107.host.secureserver.net
  • IP address: 107.180.41.169
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Dystrogen Therapeutics" on Search Engine